• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Fidelity Biosciences

edit

They are a division of Fidelity Investments, one of the world’s leading providers of financial services. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firms own capital since 1969. This provides them with the flexibility, and capabilities of traditional venture capital firms while eliminating the additional pressures of fundraising. The result is a clear focus on building long-term value for Fidelity, their management partners, and co-investors.

Recent Milestones

edit

• 
  Fidelity Biosciences invested in ViewRay. (5/21/13)
  Posted 5/21/13 at 7:18pm via pehub.com
• 
  Fidelity Biosciences invested in Iora Health. (4/17/13)
  Posted 4/18/13 at 5:38am via finsmes.com
• 
  Fidelity Biosciences invested in US HealthVest. (3/4/13)
  Posted 3/4/13 at 7:00pm via pehub.com
• 
  Fidelity Biosciences invested in Kyruus. (1/2/13)
  Posted 1/2/13 at 6:52pm via kyruus.com
• 
  Fidelity Biosciences invested in Innovent Biologics. (11/16/12)
  Posted 11/21/12 at 3:52am via fiercepharmamanufacturing.com
• 
  Fidelity Biosciences invested in Aclaris Therapeutics. (10/24/12)
  Posted 10/25/12 at 4:58am via finsmes.com
• 
  Fidelity Biosciences invested in Procured Health. (8/3/12)
  Posted 8/3/12 at 7:49pm via techcrunch.com
• 
  Fidelity Biosciences invested in Mersana Therapeutics. (7/31/12)
  Posted 7/31/12 at 7:00pm via finsmes.com
• 
  Fidelity Biosciences invested in Liazon. (4/24/12)
  Posted 4/24/12 at 7:05pm via liazon.com
• 
  Fidelity Biosciences invested in ViewRay. (3/13/12)
  Posted 3/13/12 at 6:47pm via finsmes.com
• 
  Fidelity Biosciences invested in Imagen Biotech. (10/19/11)
  Posted 10/20/11 at 3:34am via businesswire.com
• 
  Fidelity Biosciences invested in ViewRay. (9/2/11)
  Posted 9/1/11 at 10:14pm via wraltechwire.com
• 
  Fidelity Biosciences invested in Fluidnet. (8/16/11)
  Posted 8/12/11 at 6:30pm via fluidnet.net
• 
  Fidelity Biosciences invested in Ultragenyx Pharmaceutical. (6/20/11)
  Posted 6/20/11 at 6:30pm via finsmes.com
• 
  Fidelity Biosciences invested in Blueprint Medicines. (4/11/11)
  Posted 4/11/11 at 6:24pm via blueprintmedicines.com
• 
  Fidelity Biosciences invested in NextWave Pharmaceuticals. (1/11/11)
  Posted 1/11/11 at 7:30pm via finsmes.com

Investments

Videos

Sources

1. ViewRay Raises Fresh $15M for Its Medical Imaging Technology (pehub.com) [edit]
2. Iora Health Raises $14M Series B Financing (finsmes.com) [edit]
3. US HealthVest Inks $36M (pehub.com) [edit]
4. Kyruus Raises $11M Series B to Accelerate the Rapid Growth of its Physician Network Management Solutions (kyruus.com) [edit]
5. Innovent Biologics Adds $25 Million to Expand its Antibody Pipeline and its Manufacturing Capabilities (fiercepharmamanufacturing.com) [edit]
6. Aclaris Therapeutics Secures $21M in Series A Financing (finsmes.com) [edit]
7. Procured Health Nabs $1.1M From Bessemer, Athena Health Founder To Help Reduce Health Costs (techcrunch.com) [edit]
8. Mersana Therapeutics Raises $27M in Series A-1 Financing (finsmes.com) [edit]
9. Liazon Closes $18.2M in Funding to Expand Private Benefits Exchange (liazon.com) [edit]
10. ViewRay Closes $45M Series C Venture Capital Financing (finsmes.com) [edit]
11. Imagen Biotech Secures Up to $40 Million to Advance Ophthalmology Therapies (businesswire.com) [edit]
12. MRI-guided radiotherapy firm ViewRay gets $10M in new funding (wraltechwire.com) [edit]
13. FLUIDNET CORPORATION COMPLETES $25 MILLION SERIES C FINANCING (fluidnet.net) [edit]
14. Ultragenyx Pharmaceutical Closes $45M Series A Financing (finsmes.com) [edit]
15. Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments (blueprintmedicines.com) [edit]
16. NextWave Pharmaceuticals Raises $45m in a Series C Financing (finsmes.com) [edit]
17. Accuri Cytometers, Inc.: Series E $6M (onbiovc.com) [edit]
18. ViewRay Secures Series C Financing (viewray.com) [edit]
19. Vicept Therapeutics Secures $10 Million to Complete Series A Funding (vicepttx.com) [edit]
20. FoldRx banks $29M for neurodegenerative drug application (fiercebiotech.com) [edit]
21. Tetraphase hauls in $45M C round to back antibiotic work (fiercebiotech.com) [edit]
22. Accuri Cytometers, Inc.: Series D $4M (onbiovc.com) [edit]
23. Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs (reuters.com) [edit]
24. Mersana Therapeutics, Inc. Completes $21 Million Financing (mersana.com) [edit]